Doctors experimenting with new radiation treatment to combat brain tumors
A new tool the size of a postage stamp is helping destroy indestructible brain tumors.
Anthony Parise has been battling those tumors for years.
Parise was...
Advances in Stage 4 Colorectal Cancer Treatment
Podcast Transcript
Dale Shepard, MD, PhD: Cancer Advances, a Cleveland Clinic podcast for medical professionals exploring the latest innovative research and clinical advances in the...
Next-Generation JAK Inhibitors Signal the Future of Myelofibrosis Treatment Advances
Newer-generation JAK inhibitors are increasingly adept at controlling symptoms in patients with myelofibrosis and may recapture treatment response in patients who have progressed on...
Hoth Therapeutics’ Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity...
Merveille.ai Files Patent for Obesity Treatment, Begins Preparatory Steps for Clinical Trials, Joins Nvidia Developer Program
NEW YORK, March 27, 2024 /PRNewswire/ -- Hoth Therapeutics,...
Breakthrough discovery points to potential treatment for rare neurodegenerative disease
Imagine being middle-aged and starting to feel that you are off balance...
Marshall Health Network offers breakthrough minimally-invasive treatment for patients with heart...
The MitraClip™ procedure is now available at Marshall Health Network to treat individuals suffering from mitral valve regurgitation. The FDA-approved, minimally-invasive procedure addresses valve...
Denovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision...
ENLIGHTEN, a genetic biomarker–guided global late–stage clinical trial of DB104 (liafensine) for treatment–resistant depression, successfully met all major study endpointsSAN DIEGO, April 3, 2024...
Fitusiran and the Evolving Landscape
This is a video synopsis/summary of an Insights featuring Steven W. Pipe, MD.Pipe delves into the emerging therapy, fitusiran, offering a novel approach to...
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial...
An experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate autogene cevumeran continues to show potential to stimulate...
FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment...
SHANGHAI, April 7, 2024 /PRNewswire/ -- Dizal (688192.SH) today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation (BTD)...